About Clarivate JCR-based Journal Impact Factors 2025
The Journal Impact Factor is a journal-level bibliometric indicator published by Clarivate in Journal Citation Reports (JCR). It is often abbreviated as JIF; JIF is not a separate impact factor, but simply the abbreviation for Journal Impact Factor.
The 2025 Journal Impact Factor provides a journal-level indication of citation activity. It should be interpreted within the journal’s subject area and together with other information, rather than used as a stand-alone judgment of research quality.
On this website, you can explore Journal Impact Factor records presented as Clarivate JCR-based data, together with the five-year Impact Factor, JCR quartile (Q1–Q4), JCR category rank, publisher details and journal identifiers. Verify important submission or evaluation decisions in the official Clarivate Journal Citation Reports.
Browse journal metrics
Showing records 7,561–7,570 of 20,480
| Rank | Journal | ISSN / eISSN | JCR Impact Factor | 5-Year Impact Factor | JCR Quartile | JCR Category Rank | Publisher |
|---|---|---|---|---|---|---|---|
| 7,420 |
Dementia-International Journal of Social Research and Practice DEMENTIA-LONDON |
1471-3012 1741-2684 |
2.200 | 2.800 | Q2 | 18/48 | SAGE PUBLICATIONS LTD |
| 7,420 |
DERMATOLOGIC SURGERY DERMATOL SURG |
1076-0512 1524-4725 |
2.200 | 2.700 | Q2 | 95/312 | LIPPINCOTT WILLIAMS & WILKINS |
| 7,420 |
Dermatologica Sinica DERMATOL SIN |
1027-8117 2223-330X |
2.200 | 1.400 | Q2 | 45/96 | WOLTERS KLUWER MEDKNOW PUBLICATIONS |
| 7,420 |
DEVELOPMENTAL NEUROPSYCHOLOGY DEV NEUROPSYCHOL |
8756-5641 1532-6942 |
2.200 | 2.100 | Q2 | 43/102 | ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD |
| 7,420 |
DEVELOPMENTAL PSYCHOBIOLOGY DEV PSYCHOBIOL |
0012-1630 1098-2302 |
2.200 | 2.400 | Q2 | 41/93 | WILEY |
| 7,420 |
Diabetology DIABETOLOGY |
N/A 2673-4540 |
2.200 | 2.500 | Q3 | 133/191 | MDPI |
| 7,420 |
Disability and Rehabilitation-Assistive Technology DISABIL REHABIL-ASSI |
1748-3107 1748-3115 |
2.200 | 2.700 | Q1 | 43/173 | TAYLOR & FRANCIS INC |
| 7,420 |
Discourse & Communication DISCOURSE COMMUN |
1750-4813 1750-4821 |
2.200 | 2.300 | Q2 | 57/227 | SAGE PUBLICATIONS INC |
| 7,420 |
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY DRUG DEV IND PHARM |
0363-9045 1520-5762 |
2.200 | 3.100 | Q3 | 209/352 | TAYLOR & FRANCIS LTD |
| 7,420 |
Drug Metabolism and Pharmacokinetics DRUG METAB PHARMACOK |
1347-4367 1880-0920 |
2.200 | 2.200 | Q3 | 209/352 | JAPANESE SOC STUDY XENOBIOTICS |